newsfilter
← Latest News
GlobeNewswire·

ZimVie Announces Completion of its Acquisition by ARCHIMED

  • ARCHIMED completed its acquisition of ZimVie Inc. on October 20, 2025, pursuant to a transaction announced on July 20, 2025.
  • ARCHIMED acquired all outstanding shares of ZimVie stock, entitling shareholders to $19.00 in cash per share.
  • ZimVie common stock ceased trading on the NASDAQ exchange following the transaction completion.
  • André-Michel Ballester, Managing Partner at ARCHIMED, stated the partnership aims to accelerate ZimVie's growth as a global dental implant leader.
  • Centerview Partners acted as exclusive financial advisor to ZimVie, while Cravath, Swaine & Moore LLP served as legal advisor.
  • UBS Investment Bank served as exclusive financial advisor to ARCHIMED, with Latham & Watkins LLP as legal advisor.
  • ZimVie is a global life sciences leader headquartered in Palm Beach Gardens, Florida, offering dental implants, biomaterials, & digital workflow solutions.
  • ARCHIMED is a healthcare-focused investment firm managing €8 billion across Europe, North America, & Asia with priorities including MedTech & Life Science Tools.